What is the prevalence of Hypophosphatasia?

TL;DR: Hypophosphatasia (HPP) is a rare genetic metabolic disorder with a wide range of prevalence estimates, generally thought to affect approximately 1 in 100,000 live births for the severe infantile form, while milder adult forms may be significantly more common. Because Hypophosphatasia is frequently underdiagnosed or misdiagnosed as other bone conditions, the true global prevalence remains difficult to pinpoint accurately.

How common is Hypophosphatasia and why are numbers uncertain?

Hypophosphatasia is classified as a rare disease, though the spectrum of severity makes prevalence data complex. While the severe, life-threatening forms of Hypophosphatasia are estimated to occur in roughly 1 per 100,000 births, milder forms are likely under-reported. Many individuals with adult-onset Hypophosphatasia experience non-specific symptoms like chronic pain, early tooth loss, or recurring stress fractures, which are often attributed to osteoporosis or other common bone disorders. Consequently, the true prevalence is likely higher than current clinical literature suggests, as many cases remain undiagnosed within the general population.

Does Hypophosphatasia affect specific genders or ethnicities?

Hypophosphatasia is caused by mutations in the ALPL gene, which encodes the tissue-nonspecific alkaline phosphatase (TNSALP) enzyme. Because this is a genetic condition, it does not show a strong predilection for one gender over the other; males and females are affected equally. Regarding geography and ethnicity, while Hypophosphatasia occurs globally, some studies have noted higher frequencies of certain ALPL mutations in specific populations, such as the Mennonite community in Canada, where the carrier frequency is significantly elevated due to a founder effect.

What is the age of onset for Hypophosphatasia?

The clinical presentation of Hypophosphatasia is highly variable, ranging from prenatal onset to late-adulthood diagnosis. The disease is generally categorized by the age at which symptoms first appear:

• Perinatal: The most severe form, evident before birth or shortly after, often involving severe skeletal hypomineralization.


• Infantile: Onset typically occurs within the first six months of life, often presenting with failure to thrive and respiratory complications.


• Childhood: Characterized by premature loss of primary teeth and delayed motor development.


• Adult: Often presents as recurrent stress fractures, osteomalacia, and chronic musculoskeletal pain.


• Odontohypophosphatasia: A localized form where the clinical manifestation is restricted to the dental system, specifically premature tooth loss.

How does the DiseaseMaps.org community reflect the reality of the condition?

At DiseaseMaps.org, 9 people with Hypophosphatasia have joined our community to share their personal experiences. This real-world data provides a vital counterpoint to clinical statistics; it highlights that patients often spend years navigating the healthcare system before receiving an accurate diagnosis of Hypophosphatasia. By connecting with others, our members find that their "rare" symptoms—such as dental issues or unexplained fractures—are common threads within the community, validating their lived experience against the backdrop of limited epidemiological data.

Next steps

• Consult with a metabolic bone specialist or a medical geneticist to review your symptoms and clinical history.


• Request a blood test for serum alkaline phosphatase (ALP) levels if you suspect you or a family member may have Hypophosphatasia.


• Join the DiseaseMaps.org community to connect with other patients and caregivers who understand the diagnostic journey.


• Visit the Soft Bones foundation or the NIH GARD portal for updated clinical trial information and patient resources.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hypophosphatasia.


• Orphanet: Hypophosphatasia (ORPHA:418).


• OMIM (Online Mendelian Inheritance in Man): Hypophosphatasia (#241500).


• The International Society of Hypophosphatasia Experts (clinical guidelines and research).